Neuronasal
Manufacturing · Pennsylvania, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2465 Citation Ct, Wexford, Pennsylvania,...Phone Number
(617) 714-3075Website
www.neuronasal.comRevenue
$5.8 MillionIndustry
About Neuronasal
Neuronasal is focused on addressing critical medical needs through innovative treatments for Parkinson's Disease and Mild Traumatic Brain Injury. The company has developed a novel intranasal delivery method for the FDA-approved drug n-acetylcysteine (NAC), which has shown efficacy in clinical trials. Their unique approach allows for targeted drug delivery to specific brain regions, overcoming limitations of traditional dosing methods. Neuronasal aims to improve patient outcomes with its patented technology and is currently conducting Phase 1 clinical research funded by a STTR NIH/NIA grant.Explore more
SIC Code 28,283NAICS Code 32,325Show moreNeuronasal Org Chart
Compare Similar Companies to Neuronasal
Compare insights from companies similar to Neuronasal, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Neuronasal Tech Stack
A closer look at the technologies used by Neuronasal
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Neuronasal
Sign Up For FreeTo access detailed company insights
Neuronasal is focused on addressing critical medical needs through innovative treatments for Parkinson's Disease and Mild Traumatic Brain Injury. The company has developed a novel intranasal delivery method for the FDA-approved drug n-acetylcysteine (NAC), which has shown efficacy in clinical trials. Their unique approach allows for targeted drug d... Read More